NovaBridge Biosciences Cash Flow Statement (2019-2022) | NBP

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022
Operating Activities
Gains from Sales and Divestitures (Quarter) 0.09M0.12M0.16M
Gains from Investment Securities (Quarter) 1.39M0.16M0.38M0.39M
Non-cash Items (Quarter) 206.50M0.05M